デフォルト表紙
市場調査レポート
商品コード
1762469

核酸増幅検査の世界市場:市場規模・シェア・動向、業界分析 (種類別・用途別・最終用途別・地域別)、将来予測 (2025年~2034年)

Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034


出版日
ページ情報
英文 125 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
核酸増幅検査の世界市場:市場規模・シェア・動向、業界分析 (種類別・用途別・最終用途別・地域別)、将来予測 (2025年~2034年)
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の核酸増幅検査の市場規模は2034年までに288億6,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

核酸増幅検査(NAAT)は、生物学的検体内のDNAとRNAの両方を含む特定の遺伝物質をピンポイントで特定するように設計された強力な分子技術群を構成します。これらの検査の基本原理は、微量の標的核酸でも検出可能なレベルまで増幅する能力にあります。この増幅は、早期かつ正確な診断に必要な高感度を達成するために不可欠であり、特に低濃度で存在する病原体を扱う場合や、そうでなければ気づかれないかもしれない微妙な遺伝的変異を特定する場合に有効です。NAATが提供する精度と感度は、現代診断学の礎石として確立され、さまざまな医学分野の臨床判断において極めて重要な役割を果たしています。

新種の病原体の出現や既存の病原体の復活など、感染症の脅威は絶えることがないため、効果的な疾病管理と封じ込めのためには、NAATのような高感度診断ツールを広く採用する必要があります。さらに、遺伝性疾患の有病率の増加や、腫瘍学における分子診断の応用拡大が、NAATの市場需要動向の重要な促進要因となっています。分子技術の開発が進み、より迅速で使いやすく、費用対効果の高いNAATプラットフォームが開発されたことで、NAATの応用範囲と利用しやすさが広がり、これらの重要な診断アッセイの発展にさらに寄与しています。

核酸増幅検査市場:分析概要

種類別ではポリメラーゼ連鎖反応(PCR)検査が、その高い特異性、感度、さまざまな診断領域にわたる幅広い適用性により、2024年に世界最大のシェアを占めました。等温核酸増幅技術(INAAT)検査は、迅速かつポイント・オブ・ケア検査ソリューションに対する需要の高まりにより、予測期間中に最も高い成長率を示すと予測されます。

用途別では感染症検査分野が、2024年に最大シェアを占めましたが、これは幅広い感染因子の診断とモニタリングにNAATが広く使用されていることに後押しされています。腫瘍検査は、がん管理や個別化医療アプローチにおける分子診断の採用増加により、最も急成長する活用領域となる見込みです。

最終用途別では、2023年に核酸増幅検査市場で最も大きなシェアを占めたのは中央検査室および参考検査室セグメントでした。病院分野は、患者ケアの迅速化と改善を目的とした病院内での高度分子診断の統合が進んでいることから、最も高い成長率を示すと予測されています。

地域別では、北米が2024年の市場で最大のシェアを占めています。アジア太平洋の核酸増幅検査市場は、予測期間中に最も高い成長率を記録すると予測されています。

同市場で積極的に事業を展開している主な企業は、F. Hoffmann-La Roche AG、Abbott Laboratories、Thermo Fisher Scientific Inc.、QIAGEN N.V.、bioMerieux S.A.、Becton, Dickinson and Company(BD)、Siemens Healthineers AG、Danaher Corporation(Cepheid)、Hologic, Inc.、Agilent Technologies, Inc.、Illumina, Inc.などです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の核酸増幅検査市場の洞察

  • 市場スナップショット
  • 核酸増幅検査の市場力学
    • 促進要因と機会
      • 感染症の世界的な有病率の上昇
      • 遺伝性疾患の発生率の増加
    • 抑制要因と課題
      • コストが高く、特殊な機器が必要
  • PESTLE分析
  • 核酸増幅検査市場の利用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の核酸増幅検査市場:種類別

  • 主な分析結果
  • イントロダクション
  • PCR検査
  • INAAT検査
  • LCR検査

第6章 世界の核酸増幅検査市場:用途別

  • 主な分析結果
  • イントロダクション
  • 感染症検査
  • Deep Tensor
  • 腫瘍検査
  • 遺伝子・ミトコンドリア疾患検査
  • その他

第7章 世界の核酸増幅検査市場:最終用途別

  • 主な分析結果
  • イントロダクション
  • 病院
  • 中央検査室
  • 参考検査室
  • その他

第8章 世界の核酸増幅検査市場:地域別

  • 主な分析結果
  • イントロダクション
    • 核酸増幅検査市場の分析:地域別 (2020~2034年)
  • 北米
    • 北米:種類別(2020~2034年)
    • 北米:用途別(2020~2034年)
    • 北米:最終用途別(2020~2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州:種類別(2020~2034年)
    • 欧州:用途別(2020~2034年)
    • 欧州:最終用途別(2020~2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋:種類別(2020~2034年)
    • アジア太平洋:用途別(2020~2034年)
    • アジア太平洋:最終用途別(2020~2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ:種類別(2020~2034年)
    • 中東・アフリカ:用途別(2020~2034年)
    • 中東・アフリカ:最終用途別(2020~2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ:種類別(2020~2034年)
    • ラテンアメリカ:用途別(2020~2034年)
    • ラテンアメリカ:最終用途別(2020~2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company(BD)
  • bioMerieux S.A.
  • Danaher Corporation(Cepheid)
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
図表

List of Tables:

  • Table 1 Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Nucleic Acid Amplification Testing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Nucleic Acid Amplification Testing Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Nucleic Acid Amplification Testing Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Nucleic Acid Amplification Testing Market, by End Use, 2024 & 2034 (USD Billion)
目次
Product Code: PM5711

The global nucleic acid amplification testing market size is expected to reach USD 28.86 billion by 2034, according to a new study by Polaris Market Research. The report "Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Nucleic acid amplification testing, or NAAT, constitutes a powerful suite of molecular techniques designed to pinpoint specific genetic material, encompassing both DNA and RNA, within a biological specimen. The fundamental principle of these tests lies in their capacity to amplify even trace amounts of target nucleic acids to detectable levels. This amplification is essential for achieving the high sensitivity required for early and accurate diagnosis, particularly when dealing with pathogens present in low concentrations or identifying subtle genetic variations that might otherwise go unnoticed. The precision and sensitivity offered by NAAT have established it as a cornerstone in modern diagnostics, playing a pivotal role in clinical decision-making across a spectrum of medical disciplines.

The persistent threat of infectious diseases, including the emergence of novel pathogens and the resurgence of existing ones, necessitates the widespread adoption of sensitive diagnostic tools such as NAAT for effective disease management and containment. Furthermore, the increasing prevalence of genetic disorders and the expanding application of molecular diagnostics in oncology are significant drivers for the market demand trends of NAAT. Ongoing advancements in molecular technologies, leading to the development of more rapid, user-friendly, and cost-effective NAAT platforms, are also broadening their applicability and accessibility, further contributing to the development of these crucial diagnostic assays.

Nucleic Acid Amplification Testing Market Report Highlights:

By type, the polymerase chain reaction (PCR) tests segment held the largest share globally in 2024 due to their high specificity, sensitivity, and broad applicability across various diagnostic areas. Isothermal nucleic acid amplification technology (INAAT) tests are anticipated to exhibit the highest growth rate during the forecast period, driven by the increasing demand for rapid and point-of-care testing solutions.

By application, the infectious disease testing segment constituted the largest application segment in 2024, fueled by the widespread use of NAAT for diagnosing and monitoring a wide array of infectious agents. Oncology testing is expected to be the fastest-growing application segment, driven by the increasing adoption of molecular diagnostics in cancer management and personalized medicine approaches.

By end use, the central and reference laboratories segment accounted for the largest share of the nucleic acid amplification testing market in 2023, attributed to the high volume of tests processed in these facilities and their role as key hubs for specialized testing. The hospitals segment is projected to demonstrate the highest growth rate, driven by the increasing integration of advanced molecular diagnostics within hospital settings for rapid and improved patient care.

By region, North America held the largest share of the market in 2024. The Asia Pacific nucleic acid amplification testing market is projected to record the highest growth rate during the forecast period.

A few of the major players actively operating in the market are F. Hoffmann-La Roche AG; Abbott Laboratories; Thermo Fisher Scientific Inc.; QIAGEN N.V.; bioMerieux S.A.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; Danaher Corporation (Cepheid); Hologic, Inc.; Agilent Technologies, Inc.; and Illumina, Inc.

Polaris Market Research has segmented the nucleic acid amplification testing market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

PCR Tests

INAAT Tests

LCR Tests

By Application Outlook (Revenue - USD Billion, 2020-2034)

Infectious Disease Testing

Oncology Testing

Genetic & Mitochondrial Disease Testing

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Central

Reference Laboratories

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Nucleic Acid Amplification Testing Market Insights

  • 4.1. Nucleic Acid Amplification Testing Market - Market Snapshot
  • 4.2. Nucleic Acid Amplification Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Prevalence of Infectious Diseases
      • 4.2.1.2. Increasing Incidence of Genetic Disorders
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and need for specialized equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Nucleic Acid Amplification Testing Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nucleic Acid Amplification Testing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • 5.3. PCR Tests
    • 5.3.1. Global Nucleic Acid Amplification Testing Market, by PCR Tests, by Region, 2020-2034 (USD Billion)
  • 5.4. INAAT Tests
    • 5.4.1. Global Nucleic Acid Amplification Testing Market, by INAAT Tests, by Region, 2020-2034 (USD Billion)
  • 5.5. LCR Tests
    • 5.5.1. Global Nucleic Acid Amplification Testing Market, by LCR Tests, by Region, 2020-2034 (USD Billion)

6. Global Nucleic Acid Amplification Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Infectious Disease Testing
    • 6.3.1. Global Nucleic Acid Amplification Testing Market, by Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Tensor
    • 6.4.1. Global Nucleic Acid Amplification Testing Market, by Deep Tensor, by Region, 2020-2034 (USD Billion)
  • 6.5. Oncology Testing
    • 6.5.1. Global Nucleic Acid Amplification Testing Market, by Oncology Testing, by Region, 2020-2034 (USD Billion)
  • 6.6. Genetic & Mitochondrial Disease Testing
    • 6.6.1. Global Nucleic Acid Amplification Testing Market, by Genetic & Mitochondrial Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Nucleic Acid Amplification Testing Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Nucleic Acid Amplification Testing Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Central
    • 7.4.1. Global Nucleic Acid Amplification Testing Market, by Central, by Region, 2020-2034 (USD Billion)
  • 7.5. Reference Laboratories
    • 7.5.1. Global Nucleic Acid Amplification Testing Market, by Reference Laboratories, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Nucleic Acid Amplification Testing Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Nucleic Acid Amplification Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Nucleic Acid Amplification Testing Market - North America
    • 8.3.1. North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Nucleic Acid Amplification Testing Market - U.S.
      • 8.3.4.1. U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Nucleic Acid Amplification Testing Market - Canada
      • 8.3.5.1. Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Nucleic Acid Amplification Testing Market - Europe
    • 8.4.1. Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Nucleic Acid Amplification Testing Market - UK
      • 8.4.4.1. UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Nucleic Acid Amplification Testing Market - France
      • 8.4.5.1. France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Nucleic Acid Amplification Testing Market - Germany
      • 8.4.6.1. Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Nucleic Acid Amplification Testing Market - Italy
      • 8.4.7.1. Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Nucleic Acid Amplification Testing Market - Spain
      • 8.4.8.1. Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Nucleic Acid Amplification Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Nucleic Acid Amplification Testing Market - Russia
      • 8.4.10.1. Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Nucleic Acid Amplification Testing Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Nucleic Acid Amplification Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Nucleic Acid Amplification Testing Market - China
      • 8.5.4.1. China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Nucleic Acid Amplification Testing Market - India
      • 8.5.5.1. India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Nucleic Acid Amplification Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Nucleic Acid Amplification Testing Market - Japan
      • 8.5.7.1. Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Nucleic Acid Amplification Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Nucleic Acid Amplification Testing Market - South Korea
      • 8.5.9.1. South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Nucleic Acid Amplification Testing Market - Australia
      • 8.5.10.1. Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Nucleic Acid Amplification Testing Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Nucleic Acid Amplification Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Nucleic Acid Amplification Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Nucleic Acid Amplification Testing Market - UAE
      • 8.6.5.1. UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Nucleic Acid Amplification Testing Market - Israel
      • 8.6.6.1. Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Nucleic Acid Amplification Testing Market - South Africa
      • 8.6.7.1. South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Nucleic Acid Amplification Testing Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Nucleic Acid Amplification Testing Market - Latin America
    • 8.7.1. Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Nucleic Acid Amplification Testing Market - Mexico
      • 8.7.4.1. Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Nucleic Acid Amplification Testing Market - Brazil
      • 8.7.5.1. Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Nucleic Acid Amplification Testing Market - Argentina
      • 8.7.6.1. Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Nucleic Acid Amplification Testing Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Becton, Dickinson and Company (BD)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. bioMerieux S.A.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Danaher Corporation (Cepheid)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hologic, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Illumina, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. QIAGEN N.V.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens Healthineers AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development